Detalhe da pesquisa
1.
Modelling the cost-effectiveness of a newborn hearing screening programme; usability and pitfalls.
Int J Audiol
; 63(4): 235-241, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36799623
2.
Cumulative risks of false positive recall and screen-detected breast cancer after multiple screening examinations.
Int J Cancer
; 153(2): 312-319, 2023 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37038266
3.
Finding the optimal mammography screening strategy: A cost-effectiveness analysis of 920 modelled strategies.
Int J Cancer
; 151(2): 287-296, 2022 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35285018
4.
The potential of breast cancer screening in Europe.
Int J Cancer
; 148(2): 406-418, 2021 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32683673
5.
Effects of cancer screening restart strategies after COVID-19 disruption.
Br J Cancer
; 124(9): 1516-1523, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33723386
6.
Cost-Effectiveness of Neonatal Hearing Screening Programs: A Micro-Simulation Modeling Analysis.
Ear Hear
; 42(4): 909-916, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33306547
7.
Risk stratification in breast cancer screening: Cost-effectiveness and harm-benefit ratios for low-risk and high-risk women.
Int J Cancer
; 147(11): 3059-3067, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32484237
8.
MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial.
Lancet Oncol
; 20(8): 1136-1147, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31221620
9.
Cost-effectiveness of surveillance schedules in older adults with non-muscle-invasive bladder cancer.
BJU Int
; 123(2): 307-312, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30066439
10.
Summary statement on screening for prostate cancer in Europe.
Int J Cancer
; 142(4): 741-746, 2018 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29023685
11.
Comparative effectiveness of prostate cancer screening between the ages of 55 and 69 years followed by active surveillance.
Cancer
; 124(3): 507-513, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29231973
12.
The efficacy of prostate-specific antigen screening: Impact of key components in the ERSPC and PLCO trials.
Cancer
; 124(6): 1197-1206, 2018 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29211316
13.
Detection and interval cancer rates during the transition from screen-film to digital mammography in population-based screening.
BMC Cancer
; 18(1): 256, 2018 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29506487
14.
Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials.
Ann Intern Med
; 167(7): 449-455, 2017 Oct 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28869989
15.
Reply to: Comments on "Finding the optimal mammography screening strategy: A cost-effectiveness analysis of 920 modeled strategies".
Int J Cancer
; 151(4): 651-652, 2022 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35460077
16.
The effect of population-based mammography screening in Dutch municipalities on breast cancer mortality: 20 years of follow-up.
Int J Cancer
; 141(4): 671-677, 2017 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28457023
17.
When should active surveillance for prostate cancer stop if no progression is detected?
Prostate
; 77(9): 962-969, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28419541
18.
Is prostate cancer different in black men? Answers from 3 natural history models.
Cancer
; 123(12): 2312-2319, 2017 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28436011
19.
Estimating the risks and benefits of active surveillance protocols for prostate cancer: a microsimulation study.
BJU Int
; 119(4): 560-566, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27222299
20.
Estimating the individual benefit of immediate treatment or active surveillance for prostate cancer after screen-detection in older (65+) men.
Int J Cancer
; 138(10): 2522-8, 2016 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26695380